These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3918443)

  • 1. Macroprolactinemia presenting like a pituitary tumor.
    Jackson RD; Wortsman J; Malarkey WB
    Am J Med; 1985 Feb; 78(2):346-50. PubMed ID: 3918443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of macroprolactinemia in hyperprolactinemia.
    Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
    Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
    Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia.
    Kasum M; Orešković S; Čehić E; Šunj M; Lila A; Ejubović E
    Taiwan J Obstet Gynecol; 2017 Dec; 56(6):719-724. PubMed ID: 29241908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Macroprolactinemia associated with pituitary macroadenoma: treatment with quinagolide].
    Lakatos G; Szücs N; Kender Z; Czirják S; Rácz K
    Orv Hetil; 2010 Jun; 151(26):1072-5. PubMed ID: 20558354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic-pituitary function in diverse hyperprolactinemic states.
    Boyar RM; Kapen S; Finkelstein JW; Perlow M; Sassin JF; Fukushima DK; Weitzman ED; Hellman L
    J Clin Invest; 1974 Jun; 53(6):1588-98. PubMed ID: 4208470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up.
    Radavelli-Bagatini S; Lhullier FL; Mallmann ES; Spritzer PM
    Neuro Endocrinol Lett; 2013; 34(3):207-11. PubMed ID: 23685418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macroprolactinemia revisited: a study on 106 patients.
    Vallette-Kasic S; Morange-Ramos I; Selim A; Gunz G; Morange S; Enjalbert A; Martin PM; Jaquet P; Brue T
    J Clin Endocrinol Metab; 2002 Feb; 87(2):581-8. PubMed ID: 11836289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperprolactinemia: comparison of thyrotropic-releasing hormone and tomography.
    Shangold GA; Kletzky OA; Marrs RP; Mishell DR
    Obstet Gynecol; 1984 Jun; 63(6):771-5. PubMed ID: 6427715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of macroprolactinemia in the differential diagnosis of hyperprolactinemic patients.
    Bağdatoğlu C; Bağdatoğlu OT; Muslu N; Köseoğlu A; Dağtekin A; Polat G; Dolgun H; Karataş MA
    Turk Neurosurg; 2008 Jul; 18(3):223-7. PubMed ID: 18814107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholamines and pituitary function. III. Restoration of the prolactin response to thyrotropin-releasing hormone by low-dose dopamine infusion in women with pathological hyperprolactinemia.
    Nicoletti I; Filipponi P; Fedeli L; Sfrappini M; Gregorini G; Ambrosi F; Santeusanio F
    Horm Res; 1984; 20(3):202-12. PubMed ID: 6436160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential prolactin evaluation of a "cured" patient with recurrence of prolactinoma.
    Jackson RD; Malarkey WB
    Am J Med; 1987 Feb; 82(2):343-6. PubMed ID: 3812533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center.
    Chutpiboonwat P; Yenpinyosuk K; Sridama V; Kunjan S; Klaimukh K; Snabboon T
    Pan Afr Med J; 2020; 36():8. PubMed ID: 32550971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and reproductive manifestations of macroprolactinemia.
    Kalsi AK; Halder A; Jain M; Chaturvedi PK; Sharma JB
    Endocrine; 2019 Feb; 63(2):332-340. PubMed ID: 30269265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with primary hypothyroidism presenting as prolactinomas.
    Grubb MR; Chakeres D; Malarkey WB
    Am J Med; 1987 Oct; 83(4):765-9. PubMed ID: 3674063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients.
    Lu CC; Hsieh CJ
    Kaohsiung J Med Sci; 2012 Feb; 28(2):94-9. PubMed ID: 22313536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia.
    Espinós JJ; Vanrell C; Gich I; Urgell E; Calaf J
    Gynecol Endocrinol; 2017 Feb; 33(2):148-151. PubMed ID: 27841032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of functional tests in diagnosis of prolactinoma].
    Klockenbusch W; Distler W; von Ditfurth M; Graf M; Jahn K
    Geburtshilfe Frauenheilkd; 1990 May; 50(5):383-7. PubMed ID: 2115483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of pituitary function in patients with serum prolactin levels greater than 100 ng/ml.
    Blackwell RE; Boots LR; Goldenberg RL; Younger JB
    Fertil Steril; 1979 Aug; 32(2):177-82. PubMed ID: 572785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of Macroprolactin in Hyperprolactinemia.
    Sherazi NA; Baig MZ; Khan AH
    J Coll Physicians Surg Pak; 2018 Feb; 28(2):93-97. PubMed ID: 29394965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.